Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Asia Pacific Blood Glucose Monitoring Market, by Product Type
6.1 Introduction
6.2 Invasive Glucose Monitoring Devices
6.2.1 Market Estimates & Forecast, 2023-2032
6.3 Continuous Glucose Monitoring Devices
6.3.1 Market Estimates & Forecast, 2023-2032
6.4 Flash Glucose Monitoring Devices
6.4.1 Market Estimates & Forecast, 2023-2032
6.5 Others
7. Asia Pacific Blood Glucose Monitoring Market, by Application
7.1 Introduction
7.2 Type 1 Diabetes
7.2.1 Market Estimates & Forecast, 2023-2032
7.3 Type 2 Diabetes
7.3.1 Market Estimates & Forecast, 2023-2032
7.4 Others
7.4.1 Market Estimates & Forecast, 2023-2032
8. Asia Pacific Blood Glucose Monitoring Market, by End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2023-2032
8.3 Diagnostic Centers
8.3.1 Market Estimates & Forecast, 2023-2032
8.4 Clinics
8.4.1 Market Estimates & Forecast, 2023-2032
8.5 Research centers
8.5.1 Market Estimates & Forecast, 2023-2032
8.6 Homecare Diagnostics
8.6.1 Market Estimates & Forecast, 2023-2032
9. Asia Pacific Blood Glucose Monitoring Market, by Region
9.1 Introduction
9.2 Japan
9.3 China
9.4 India
9.5 Republic of Korea
9.6 Australia
9.7 Rest of Asia Pacific
10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Arkay, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bayer Healthcare AG
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 F. Hoffmann-La Roche
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Goldsite Diagnostics Inc.
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 GlySure Ltd
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Sphere Medical
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Dexcom, Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 LifeScan
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Others
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Pharmaceutical Industry
13 Appendix
LIST OF TABLES
Table 1 Blood glucose monitoring Industry Synopsis, 2023-2032
Table 2 Asia Pacific Blood glucose monitoring Market Estimates and Forecast, 2023-2032, (USD Million)
Table 3 Asia Pacific Blood glucose monitoring Market by Country, 2023-2032, (USD Million)
Table 4 Asia Pacific Blood glucose monitoring Market by Product Type, 2023-2032, (USD Million)
Table 5 Asia Pacific Blood glucose monitoring Market by Application, 2023-2032, (USD Million)
Table 6 Asia Pacific Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
Table 7 Japan Blood glucose monitoring Market by Types, 2023-2032, (USD Million)
Table 8 Japan Blood glucose monitoring Market by Application, 2023-2032, (USD Million)
Table 9 Japan Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
Table 10 China Blood glucose monitoring Market by Types, 2023-2032, (CHINAD Million)
Table 11 China Blood glucose monitoring Market by Application, 2023-2032, (CHINAD Million)
Table 12 China Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
Table 13 India Blood glucose monitoring Market by Types, 2023-2032, (USD Million)
Table 14 India Blood glucose monitoring Market by Application, 2023-2032, (USD Million)
Table 15 India Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
Table 16 Republic of Korea Blood glucose monitoring Market by Types, 2023-2032, (USD Million)
Table 17 Republic of Korea Blood glucose monitoring Market by Application, 2023-2032, (USD Million)
Table 18 Republic of Korea Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
Table 19 Australia Blood glucose monitoring Market by Types, 2023-2032, (USD Million)
Table 20 Australia Blood glucose monitoring Market by Application, 2023-2032, (USD Million)
Table 21 Australia Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
Table 22 Rest of Asia Pacific Blood glucose monitoring Market by Types, 2023-2032, (USD Million)
Table 23 Rest of Asia Pacific Blood glucose monitoring Market by Application, 2023-2032, (USD Million)
Table 24 Rest of Asia Pacific Blood glucose monitoring Market by End User, 2023-2032, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Asia Pacific Blood Glucose Monitoring Market
Figure 3 Segmentation Market Dynamics for Blood Glucose Monitoring Market
Figure 4 Asia Pacific Blood Glucose Monitoring Market Share, by Product Type 2020
Figure 5 Asia Pacific Blood Glucose Monitoring Market Share, by Application 2020
Figure 6 Asia Pacific Blood Glucose Monitoring Market Share, by End User, 2020
Figure 7 Asia Pacific Blood Glucose Monitoring Market Share, by Country, 2020
Figure 8 Asia Pacific Blood Glucose Monitoring Market: Company Share Analysis, 2020 (%)
Figure 9 Abbott Laboratories.: Key Financials
Figure 10 Abbott Laboratories.: Segmental Revenue
Figure 11 Abbott Laboratories.: Geographical Revenue
Figure 12 Arkay, Inc.: Key Financials
Figure 13 Arkay, Inc.: Segmental Revenue
Figure 14 Arkay, Inc.: Geographical Revenue
Figure 15 Bayer Healthcare AG: Key Financials
Figure 16 Bayer Healthcare AG: Segmental Revenue
Figure 17 Bayer Healthcare AG: Geographical Revenue
Figure 18 F. Hoffmann-La Roche: Key Financials
Figure 19 F. Hoffmann-La Roche: Segmental Revenue
Figure 20 F. Hoffmann-La Roche: Geographical Revenue
Figure 21 Goldsite Diagnostics Inc.: Key Financials
Figure 22 Goldsite Diagnostics Inc.: Segmental Revenue
Figure 23 Goldsite Diagnostics Inc.: Geographical Revenue
Figure 24 GlySure Ltd: Key Financials
Figure 25 GlySure Ltd: Segmental Revenue
Figure 26 GlySure Ltd: Geographical Revenue
Figure 27 Sphere Medical: Key Financials
Figure 28 Sphere Medical: Segmental Revenue
Figure 29 Sphere Medical: Geographical Revenue
Figure 30 Dexcom, Inc.: Key Financials
Figure 31 Dexcom, Inc.: Segmental Revenue
Figure 32 Dexcom, Inc.: Geographical Revenue
Figure 33 LifeScan: Key Financials
Figure 34 LifeScan: Segmental Revenue
Figure 35 LifeScan: Geographical Revenue